PF582

· Pfenex, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF582, covering 2016-05-11 to 2016-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration [Phase 1, Phase 2]